financetom
Business
financetom
/
Business
/
Solen Software Group Acquires Trackit LLC
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Solen Software Group Acquires Trackit LLC
Mar 11, 2026 7:11 AM

SALT LAKE CITY--(BUSINESS WIRE)--

Solen Software Group announced the acquisition of Trackit LLC, a provider of transit-specific, cloud-based SaaS software that helps public transportation agencies work together through a configurable, paperless system supporting compliance and cross-department collaboration. The transaction closed in February 2026.

Founded by Mark Anderson in 2013, Trackit delivers a hosted solution that brings an agency’s data and information together in one simple system without turning software into a complex IT project. By replacing paper-based workflows with searchable digital records, Trackit helps agencies reduce manual reporting, eliminate duplicate data entry, and stay audit-ready.

Trackit’s platform is designed to break down information silos by enabling data entered one time to be shared across departments as agencies decide, with permissions-based access. Trackit supports PTASP compliance and broader safety and compliance needs, including accident management, mandatory employee safety reporting, training management, form compliance, safety notifications, and drug and alcohol reporting. More than 100 transit agencies have adopted Trackit to develop agency-wide safety plans with sophisticated record keeping.

Trackit includes a suite of modules to fit agency needs, such as Attendance, Claims, Compliance, Customer Service, Doc/Date Compliance, eLearning, Event Logging, Form Compliance, Form Manager, and HR Manager, along with training and support included in the license. Trackit also offers rapid implementation, with agencies able to get up and running in as little as one day.

“Trackit has grown significantly, now supporting over 100 transit locations in running their agencies more effectively. After looking at various options to move into the future, we believe Solen Software Group, as a permanent home, will allow us to grow and better service our Transit customers,” said Mark Anderson, President of Trackit. "Trackit's vision continues, and customers can expect the same high level of support with all the same people involved."

“Solen is a permanent home for enduring, customer-centric software companies,” said Alexander Spencer, Founder and CEO of Solen Software Group. “Trackit has built deep trust with transit agencies by making compliance, recordkeeping, and cross-department collaboration simpler without adding IT burden. We’re excited to invest in the product, support the team, and help more agencies modernize operations with confidence.”

Trackit Transit will continue operating with autonomy, with Solen supporting the business through long-term ownership and optional shared services, allowing the Trackit team to remain focused on product development and customer support.

About Solen Software Group

Solen Software Group is a permanent-capital acquirer and operator of resilient, mission-critical software businesses serving enterprise B2B markets. The company partners with founders to acquire, grow, and sustain niche SaaS businesses, preserving their core values while providing long-term support for product innovation, customer success, and team development.

Solen takes a founder-first approach, operating without predefined exit timelines and investing for decades to strengthen each company’s legacy. Its decentralized operating model empowers portfolio leadership teams to make decisions close to customers, supported by shared playbooks in growth strategy, digital transformation, and operational excellence.

Solen’s investment philosophy centers on high retention, recurring revenue, and sustainable growth, with a global footprint that includes offices in Salt Lake City, New York, Toronto, Lisbon, and Rio de Janeiro.

For additional information about Solen Software Group, please visit www.solensoftwaregroup.com.

Forward-looking statements

This press release may contain forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those expressed or implied.

Source: Solen Software Group

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rheinmetall wants to take over German shipbuilder NVL, Bild reports
Rheinmetall wants to take over German shipbuilder NVL, Bild reports
Aug 27, 2025
BERLIN, Aug 27 (Reuters) - Defence group Rheinmetall wants to take over German shipbuilder Naval Vessels Luerssen, the German daily Bild reported on Wednesday, citing industry sources. According to Bild, the Luerssen family, who own the shipbuilder, plan to divest its military shipyards in Hamburg, Wilhelmshaven and Wolgast to focus on building megayachts. Rheinmetall's supervisory board intends to consider the...
Abercrombie & Fitch Lifts Full-Year Guidance as Second-Quarter Results Top Views
Abercrombie & Fitch Lifts Full-Year Guidance as Second-Quarter Results Top Views
Aug 27, 2025
01:20 PM EDT, 08/27/2025 (MT Newswires) -- Abercrombie & Fitch ( ANF ) upgraded its fiscal 2025 outlook on Wednesday after the apparel retailer's second-quarter results exceeded Wall Street's estimates, though earnings fell year over year. The company now expects full-year earnings between $10 and $10.50 per share, lifting the middle point versus its prior outlook of $9.50 to $10.50....
BRIEF-CCH Holdings Files For U.S IPO With SEC - SEC Filing
BRIEF-CCH Holdings Files For U.S IPO With SEC - SEC Filing
Aug 27, 2025
Aug 27 (Reuters) - CCH Holdings Ltd: * CCH HOLDINGS LTD - FILES FOR US IPO WITH SEC - SEC FILING * CCH HOLDINGS LTD - TO APPLY FOR NASDAQ LISTING UNDER SYMBOL 'CCHH' - SEC FILING * CCH HOLDINGS LTD: CATHAY SECURITIES INC IS UNDERWRITER TO IPO ;)) ...
Vor Bio's Investigational Drug Scores Phase 3 Win In Autoimmune Kidney Disease Trial
Vor Bio's Investigational Drug Scores Phase 3 Win In Autoimmune Kidney Disease Trial
Aug 27, 2025
On Wednesday, Vor Bio Inc. announced that its collaborator, RemeGen Co., Ltd., achieved the primary endpoint in Stage A of a Phase 3 clinical study in China evaluating telitacicept in adults with IgA nephropathy (IgAN). IgA nephropathy, also known as Berger’s disease, is an autoimmune kidney disease where abnormal clumps of the antibody immunoglobulin A (IgA) deposit in the kidneys’...
Copyright 2023-2026 - www.financetom.com All Rights Reserved